Last $2.65 USD
Change Today +0.03 / 1.15%
Volume 375.7K
ATRS On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 5:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

antares pharma inc (ATRS) Snapshot

Open
$2.64
Previous Close
$2.62
Day High
$2.68
Day Low
$2.58
52 Week High
01/15/14 - $5.01
52 Week Low
09/30/14 - $1.82
Market Cap
349.0M
Average Volume 10 Days
1.2M
EPS TTM
$-0.23
Shares Outstanding
131.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ANTARES PHARMA INC (ATRS)

Related News

No related news articles were found.

antares pharma inc (ATRS) Related Businessweek News

View More BusinessWeek News

antares pharma inc (ATRS) Details

Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. The company’s injection products include OTREXUP, a pre-filled methotrexate syringe with Medi-Jet technology to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; and Tjet/Zomajet, the needle-free auto injectors to deliver human growth hormone treatment to children without the use of a needle. Its transdermal products comprise Gelnique3%, an oxybutynin gel product for the treatment of overactive bladder; and Elestrin, a transdermal estradiol gel for the treatment of moderate-to-severe vasomotor symptoms associated with menopause. The company is also developing OTREXUP for the treatment poly-articular-course juvenile RA and psoriasis; Vibex QS T for testosterone replacement therapy for men suffering from symptomatic testosterone deficiency; Vibex auto injectors; and disposable pen injectors. Antares Pharma, Inc. has collaborative and license agreements with Ferring Pharmaceuticals BV; Teva Pharmaceutical Industries, Ltd.; JCR Pharmaceuticals Co., Ltd.; Actavis, Inc.; Daewoong Pharmaceuticals; Meda Pharmaceuticals; Pfizer Inc; Population Council; and LEO Pharma. The company was founded in 1979 and is headquartered in Ewing, New Jersey.

60 Employees
Last Reported Date: 03/13/14
Founded in 1979

antares pharma inc (ATRS) Top Compensated Officers

Chief Operating Officer and Executive Vice Pr...
Total Annual Compensation: $360.0K
Compensation as of Fiscal Year 2013.

antares pharma inc (ATRS) Key Developments

Antares Pharma Inc. Presents at Oppenheimer 25th Annual Healthcare Conference, Dec-10-2014 03:55 PM

Antares Pharma Inc. Presents at Oppenheimer 25th Annual Healthcare Conference, Dec-10-2014 03:55 PM. Venue: The Crowne Plaza Hotel, New York, New York, United States. Speakers: Eamonn P. Hobbs, Chief Executive Officer, President, Director, Member of Audit Committee and Member of Governance & Nominating Committee.

Antares Pharma Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014 12:30 PM

Antares Pharma Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014 12:30 PM. Venue: The New York Palace Hotel, 455 Madison Ave, New York, NY 10022, United States. Speakers: Eamonn P. Hobbs, Chief Executive Officer, President, Director, Member of Audit Committee and Member of Governance & Nominating Committee.

Antares Pharma, Inc. Appoints James E. Fickenscher to the Position of Senior Vice President and Chief Financial Officer

Antares Pharma Inc. announced the appointment of James E. Fickenscher to the position of Senior Vice President and Chief Financial Officer. Mr. Fickenscher has a diversified corporate background including more than 25 years of experience in the pharmaceutical industry. Most recently, Mr. Fickenscher served as Chief Financial Officer of Auxilium Pharmaceuticals Inc. from May 2005 until August 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATRS:US $2.65 USD +0.03

ATRS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biolase Inc $2.64 USD -0.065
Cerus Corp $6.49 USD +0.29
Pluristem Therapeutics Inc $2.46 USD 0.00
STAAR Surgical Co $9.11 USD -0.08
SurModics Inc $21.90 USD +0.11
View Industry Companies
 

Industry Analysis

ATRS

Industry Average

Valuation ATRS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 15.2x
Price/Book 6.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 13.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANTARES PHARMA INC, please visit www.antarespharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.